Gene · 7408
Papers3,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Determinants for Suture-mediated Closure Device Failure During EVAR Procedures. | Vasc Endovascular Surg | 2024 | 37450890 | PubTator, text mining | PubMed |
| Simultaneous proteome localization and turnover analysis reveals spatiotemporal features of protein homeostasis disruptions. | bioRxiv | 2024 | 36711879 | PubTator, text mining | PubMed |
| Liquid-like VASP condensates drive actin polymerization and dynamic bundling. | Nat Phys | 2023 | 38405682 | PubTator, text mining | PubMed |
| A Novel Homozygous Loss-of-Function Variant in SPRED2 Causes Autosomal Recessive Noonan-like Syndrome. | Genes (Basel) | 2023 | 38254922 | PubTator, text mining | PubMed |
| The AM-4 Family of Layered Titanosilicates: Single-Crystal-to-Single-Crystal Transformation, Synthesis and Ionic Conductivity. | Materials (Basel) | 2023 | 38203965 | PubTator, text mining | PubMed |
| Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases. | Front Pharmacol | 2023 | 38186653 | PubTator, text mining | PubMed |
| Pan-cancer analysis of homeodomain-containing gene C10 and its carcinogenesis in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 38154103 | PubTator, text mining | PubMed |
| Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens. | Sci Rep | 2023 | 38151494 | PubTator, text mining | PubMed |
| Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal Cancers. | Pharmaceutics | 2023 | 38140110 | PubTator, text mining | PubMed |
| Therapeutic Potential for Beta-3 Adrenoreceptor Agonists in Peripheral Arterial Disease and Diabetic Foot Ulcers. | Biomedicines | 2023 | 38137408 | PubTator, text mining | PubMed |
| Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. | Sci Rep | 2023 | 38114514 | PubTator, text mining | PubMed |
| Anti-thrombotic effects of ginsenoside Rk3 by regulating cAMP and PI3K/MAPK pathway on human platelets. | J Ginseng Res | 2023 | 38107398 | PubTator, text mining | PubMed |
| Advances and Perspectives in methods for identifying high platelet reactivity. | Heliyon | 2023 | 38107326 | PubTator, text mining | PubMed |
| Visible Light-Induced Specific Protein Reaction Delineates Early Stages of Cell Adhesion. | J Am Chem Soc | 2023 | 38104267 | PubTator, text mining | PubMed |
| Thy-1 (CD90)-regulated cell adhesion and migration of mesenchymal cells: insights into adhesomes, mechanical forces, and signaling pathways. | Front Cell Dev Biol | 2023 | 38099295 | PubTator, text mining | PubMed |
| Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia. | Cancer Med | 2023 | 38069522 | PubTator, text mining | PubMed |
| Actin Isoform Composition and Binding Factors Fine-Tune Regulatory Impact of Mical Enzymes. | Int J Mol Sci | 2023 | 38068973 | PubTator, text mining | PubMed |
| Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity. | Cells | 2023 | 38067122 | PubTator, text mining | PubMed |
| Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer. | Cell Death Dis | 2023 | 38062011 | PubTator, text mining | PubMed |
| Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer. | Front Pharmacol | 2023 | 38026933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7408/papers?page=10